Abstract:ctive: In light of their diverse molecular features and wide range of biological activities, compounds with coumarin-based chemical structures have drawn significant scientific interest. On the other hand, despite the massive development of anti-aerobic bacterial agents, those that fight anaerobic bacteria are less advanced. Methods: In this work, 3-halomequinol derivatives were condensed via a Pechmann coupling reaction with 3-oxopentanedioic acid, affording precursors named 7-halo-6-methoxycoumarin-4-acetic acids and coded ( P1–P4 ). These were esterified with metronidazole by thionyl chloride to give the four new coumarin-metronidazole composites coded ( COU–MTZ1 – COU–MTZ4 ). The structural conformation of these composites and their corresponding precursors was determined by analyzing the spectra acquired from FT-IR, 1 H NMR, and 13 C NMR spectrophotometers. The anti-anaerobic bacterial activity was assessed by determining the composites' inhibitory impact against four strains of pathogenic bacteria using broth dilution as a methodology. The biocompatibility profiles of the synthesized composites were spotlighted by in vitro inspection as well as by following their effects on the cellular growth of two normal-type bacterial strains and three healthy-type cell lines. Finally, the possibility of the composites being drug candidates was checked in silico by calculating their pharmacokinetic and drug-like attributes. Results: The results indicated that the new composites are biocompatible and demonstrated improved activity relative to the reference, with a golden effect attributed to the flouro-based composite. Discussion: This work reports the success in the synthesis and characterization of four ( COU–MTZ ) composites and their precursors. The synthetic composites showed more promising anti-anaerobic bacterial activity than the parent drug, with better theoretical aqueous solubility, intestinal absorption, and association with plasma proteins. Concerning the biocompatibility study, the synthetic composites did not demonstrate any obvious negative impact on the cellular growth of two normal-type bacterial strains and three healthy-type cell lines. Conclusions: It is concluded that the conjugation of metronidazole with the synthesized coumarins can improve its lipophilicity and consequently the candidate's penetration into the test anaerobic pathogens, affording a promising synthon template for advanced research.

Coumarin derivatives as promising antibacterial agent(s)

Molecular Insights into Coumarin Analogues as Antimicrobial Agents: Recent Developments in Drug Discovery

Coumarin‐containing hybrids and their antibacterial activities

Coumarin: A Renowned Moiety for Gram-Negative Escherichia coli – a Review

Synthesis, biofilm formation inhibitory, and inflammation inhibitory activities of new coumarin derivatives

Coumarins as versatile therapeutic phytomolecules: A systematic review

Synthesis and Molecular Docking Study of Some New Thiazole-coumarin Molecular Hybrids as Antibacterial Agents

Current Developments of Coumarin Compounds in Medicinal Chemistry

Coumarins as Potential Antiprotozoal Agents: Biological Activities and Mechanism of Action

Identification of coumarin - benzimidazole hybrids as potential antibacterial agents: Synthesis, in vitro and in vivo biological assessment, and ADMET prediction

Coumarins: Quorum Sensing and Biofilm Formation Inhibition

Multimodal antibacterial potency of newly designed and synthesized Schiff's/Mannich based coumarin derivatives: potential inhibitors of bacterial DNA gyrase and biofilm production

Design, synthesis, molecular docking and antimicrobial and antimycobacterial activities of novel hybrid of coumarin-cinnamic acids

Synthesis and antibacterial evaluation of new naphthalimide-coumarin hybrids against multidrug-resistant S. aureus and M. tuberculosis

Pharmacological And Nutritional Effects Of Natural Coumarins And Their Structure-Activity Relationships

Synthesis and Evaluation of New Coumarin Derivatives as Antioxidant, Antimicrobial, and Anti-Inflammatory Agents

Coumarin hybrids: a sighting of their roles in drug targeting

Coumarin (2H-1-Benzopyran-2-one) act against planktonic and biofilm forms of Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa

New Coumarin-Metronidazole Composites: Synthesis, Biocompatibility, and Anti-anaerobic Bacterial Activity

Coumarin-transition metal complexes with biological activity: current trends and perspectives

Pharmacological and Nutritional Effects of Natural Coumarins and Their Structure–Activity Relationships